High-yield overview

Medial Knee Pain | Sartorius-Gracilis-Semitendinosus | Common in Obese and OA

5-6cmLocation below medial joint line

2.5%Of knee MRIs for suspected internal derangement

VariableRecovery 10 days to 36 months

F:M 4:1Female predominance

CLINICAL PATTERN

Primary

PatternOveruse in athletes/runners

TreatmentActivity modification, physio, NSAIDs

Secondary to OA

PatternAssociated with knee osteoarthritis

TreatmentTreat underlying OA, consider injection

Traumatic

PatternDirect blow to medial knee

TreatmentRICE, graduated return to activity

Critical Must-Knows

SGS mnemonic - Sartorius, Gracilis, Semitendinosus form the pes anserinus (goose foot)
Location 5-6cm below joint line - distinguishes from medial compartment OA or MCL pathology
Associated with obesity and knee OA - treat underlying conditions for lasting relief
Injection technique - target 2cm distal and 2cm medial to tibial tuberosity
Often misdiagnosed as medial meniscal tear or MCL injury - key differentiating feature is tenderness location

Clinical Pearls

“
Pes anserine tendons insert on anteromedial tibia 5-6cm below joint line
“
All three muscles cross both hip and knee joints (except short head biceps)
“
Saphenous nerve runs posterior to pes anserinus - at risk with injection
“
Bursa lies between MCL and conjoined tendon insertion

Overview and Epidemiology

Pes anserine bursitis is inflammation of the anserine bursa on the anteromedial aspect of the proximal tibia. "Pes anserinus" is Latin for "goose foot", after the fan-shaped appearance of the three tendons that insert there. It is a common but often underdiagnosed cause of medial knee pain, particularly in middle-aged obese women with concurrent knee osteoarthritis.

Who. Incidence peaks between 40 and 60 years, with a marked female predominance of 4:1 and a strong association with obesity (BMI greater than 30). It is also common in runners and athletes whose activities involve repetitive knee flexion.

How common. It was found on 2.5% of knee MRI scans requested for suspected internal derangement (Rennie 2005). That is a radiology-report prevalence in a referred population, not a rate among patients with knee osteoarthritis or with medial knee pain generally.

Associations. Obesity, knee osteoarthritis and valgus malalignment are strong associations and a common triad, knee osteoarthritis being the most common. Diabetes mellitus carries a strong, independent association, with about 36% of type 2 diabetics affected in Cohen's 1997 series. Others:

Metabolic syndrome
Type II collagen disorders
Pes planus (flat foot)
Tight hamstrings

Association with Knee OA

Pes anserine bursitis frequently coexists with medial compartment knee osteoarthritis. In patients with knee OA presenting with medial knee pain, always examine the pes anserinus region - the bursitis may be the primary pain generator and is more amenable to treatment than the underlying OA.

Mechanism. The bursa becomes inflamed through repetitive friction between the pes anserine tendons and the underlying tibial bone or MCL. The causes:

Overuse from running and training errors, especially increasing distance rapidly
Repetitive knee flexion activities (cycling, breaststroke swimming)
Direct trauma to the medial knee
Chronic mechanical irritation from valgus malalignment

Pathophysiology and Anatomy

The pes anserinus. The conjoined tendons of three muscles insert on the anteromedial surface of the proximal tibia, approximately 5-6 cm distal to the medial joint line, fanning out like a goose's foot. From superficial to deep they are sartorius, gracilis and semitendinosus (SGS): "Say Grace before Semitendinosus".

Sartorius

Origin: ASIS
Innervation: Femoral nerve (L2-3)
Primary Action: Hip flexion and external rotation, knee flexion, tibial internal rotation

Gracilis

Origin: Inferior pubic ramus
Innervation: Obturator nerve (L2-3)
Primary Action: Hip adduction, knee flexion, internal rotation

Semitendinosus

Origin: Ischial tuberosity
Innervation: Sciatic nerve (tibial division L5-S2)
Primary Action: Hip extension, knee flexion, internal rotation

Pes Anserinus Components
Muscle	Origin	Innervation	Primary Action
Sartorius	ASIS	Femoral nerve (L2-3)	Hip flexion and external rotation, knee flexion, tibial internal rotation
Gracilis	Inferior pubic ramus	Obturator nerve (L2-3)	Hip adduction, knee flexion, internal rotation
Semitendinosus	Ischial tuberosity	Sciatic nerve (tibial division L5-S2)	Hip extension, knee flexion, internal rotation

Two-joint muscles. All three cross both the hip and the knee, which makes them prone to strain with activities involving simultaneous hip and knee motion.

The bursa. The anserine bursa lies deep to the pes anserine tendon insertion and superficial to the tibial attachment of the MCL, on the anteromedial proximal tibia. It lets the tendons glide over the underlying MCL and tibial periosteum, and in some individuals a separate bursa may exist between each tendon.

The MCL. The superficial MCL inserts on the tibial metaphysis, deep to the pes anserine insertion, so the bursa lies between the two structures. MCL pathology can cause similar medial knee pain, but the tenderness is at the joint line.

The saphenous nerve. The saphenous nerve runs posterior to the pes anserinus. Its infrapatellar branch runs in close proximity, passing anterior to the sartorius tendon before crossing medially, and is at risk during:

Corticosteroid injection of the bursa
Medial knee arthroscopy portals
Harvesting of hamstring grafts for ACL reconstruction

Two panels: ultrasound of sartorius and the infrapatellar branch of the saphenous nerve annotated with asterisks, an arrow and arrowheads, and the ultrasound probe position — Ultrasound of sartorius and the infrapatellar branch of the saphenous nerve (A, annotated with asterisks, an arrow and arrowheads), with the probe position used to obtain it (B).Credit: Miyata et al., Cureus (CC BY 4.0)

Pathophysiology. Repetitive movement causes friction and mechanical irritation, and valgus alignment adds compression by increasing load on the medial structures. Age-related degeneration decreases bursal resilience. Among systemic factors, diabetes is thought to impair tissue healing and predispose to inflammation, although the mechanism behind its association with the condition remains unexplained (see Controversies).

Dynamic Medial Stabilisation by the Pes Anserinus

Beyond being a source of medial pain, the pes anserine group is a functionally important dynamic stabiliser of the medial knee. Sartorius, gracilis and semitendinosus all cross the knee posteromedially and insert anterior to the tibial axis of rotation. Their conjoined pull therefore flexes the knee and internally rotates the tibia, opposing the obligate external rotation of terminal extension (the screw-home mechanism).

Secondary restraint. The pes anserinus acts as a secondary dynamic restraint to valgus load and to anteromedial rotatory instability. It supplements the superficial MCL, which remains the primary static valgus restraint (see the MCL injuries topic).

The hamstring graft. Semitendinosus and gracilis, acting as tibial internal rotators, help resist the anterolateral rotatory subluxation that characterises anterior cruciate ligament deficiency; this dynamic contribution is one reason the semitendinosus-gracilis (hamstring) tendons are a mainstay ACL graft. Harvesting them removes part of this dynamic medial support, a consideration when a patient with a previous hamstring-graft ACL reconstruction later presents with medial knee symptoms.

Why the hip matters. Valgus malalignment and weak frontal-plane control (weak gluteus medius, valgus thrust) chronically overload the medial soft tissues and the pes anserine complex. That is why hip-abductor and gluteus medius strengthening, not just local treatment of the bursa, is central to durable rehabilitation and to preventing recurrence. Examiners look for this point when you discuss rehabilitation strategy.

Clinical Presentation

The pain. Medial knee pain, specifically below the joint line, described as aching, burning or sharp. Onset is usually gradual and may follow an increase in activity. Stairs (especially descending), rising from a chair and pivoting aggravate it, and morning stiffness is common but lasts less than 30 minutes.

Night Pain Pattern

Night pain when lying on the affected side is characteristic: patients often report it, from direct pressure on the inflamed bursa. This distinguishes it from OA pain, which typically improves with rest. Asking about sleeping position is a valuable history question.

Associated symptoms. Localised swelling over the medial tibia, stiffness of the knee, difficulty with activities requiring knee flexion, and pain-limited weakness of knee flexion.

Inspection. Look for localised swelling over the anteromedial proximal tibia, which may be subtle, and for valgus malalignment, which may be present. Watch the gait for a valgus thrust. There is no knee joint effusion.

Palpation. The finding is point tenderness 5-6 cm below the medial joint line, over the anteromedial tibial surface, and a distended bursa may feel boggy. There is no joint-line tenderness unless there is concurrent meniscal pathology, but read the caution on joint-line pain under Differential Diagnosis before relying on that.

Provocative tests. A positive test reproduces pain at the pes anserine region or the anteromedial tibia.

Resisted knee flexion

Technique: Patient supine, examiner resists knee flexion from 90 degrees
Positive Finding: Pain at pes anserine region

Resisted internal rotation

Technique: Patient seated, knee at 90 degrees, resist tibial internal rotation
Positive Finding: Pain at anteromedial tibia

Passive valgus stress

Technique: Valgus stress to extended knee
Positive Finding: Pain over pes anserinus (not joint line)

Hamstring stretch

Technique: Passive knee extension with hip flexed to 90 degrees
Positive Finding: Pain at anteromedial tibia

Clinical Tests for Pes Anserine Bursitis
Test	Technique	Positive Finding
Resisted knee flexion	Patient supine, examiner resists knee flexion from 90 degrees	Pain at pes anserine region
Resisted internal rotation	Patient seated, knee at 90 degrees, resist tibial internal rotation	Pain at anteromedial tibia
Passive valgus stress	Valgus stress to extended knee	Pain over pes anserinus (not joint line)
Hamstring stretch	Passive knee extension with hip flexed to 90 degrees	Pain at anteromedial tibia

Differential Diagnosis Red Flags

The following findings suggest alternative diagnosis and require further investigation:

Joint line tenderness (meniscal injury, OA)
Knee joint effusion (intra-articular pathology)
Instability on valgus stress (MCL injury)
Mechanical symptoms - locking, giving way (meniscal tear)
Systemic symptoms - fever, weight loss (infection, malignancy)

Investigations

Pes anserine bursitis is primarily a clinical diagnosis. Investigations are used to exclude other pathology and to confirm the diagnosis in unclear cases.

Radiographs. AP, lateral and skyline views are usually normal in isolated pes anserine bursitis. They may show concurrent medial compartment osteoarthritis and exclude other bony pathology such as stress fracture or tumour.

Ultrasound is the investigation of choice for confirming the diagnosis and is useful for guiding injection. The diagnosis is supported by an anechoic or hypoechoic fluid collection at the bursa with bursal thickness greater than 2 mm. The examination should include the pes anserine tendons, for concurrent tendinopathy, and the MCL, for associated pathology. How often it finds no bursa at all in a clinically diagnosed case is taken up under Controversies.

Ultrasound with a hypoechoic area (star) beneath the structure labelled PATT and above the border of the tibia — Ultrasound of pes anserine bursitis: a hypoechoic area (star) lies beneath the structure labelled PATT and above the border of the tibia (arrows), with lateral to the right of the image.Credit: Mun et al., Medicine (CC BY 4.0)

MRI is reserved for diagnostic uncertainty or suspected concurrent pathology. It shows high T2 signal in the bursal region and the extent of bursal distension, may reveal concurrent tendinopathy of the pes anserine tendons, and assesses the menisci, ligaments and articular cartilage.

Laboratory tests are not routinely required. Consider them in atypical presentations:

ESR and CRP if infection is suspected
Uric acid if gout is suspected
Rheumatoid factor and anti-CCP if inflammatory arthritis is suspected
HbA1c to screen for diabetes in recurrent cases

Medial Periarticular Fluid Collections that Mimic the Anserine Bursa

Rennie's MRI series (Rennie 2005) emphasised that anserine bursal fluid must be distinguished on axial imaging from other medial periarticular fluid collections. Several of them produce medial knee pain or a palpable medial swelling and are routinely mislabelled as anserine bursitis.

Pes anserine bursa

Location: Deep to conjoined tendons, superficial to distal MCL, anteromedial tibia
Distinguishing feature: Fluid below the joint line at the tendon insertion

Semimembranosus-tibial collateral ligament bursa

Location: Between semimembranosus tendon and superficial MCL, posteromedially at or above the joint line
Distinguishing feature: Sits more posterior and higher than the anserine bursa

MCL (tibial collateral ligament) bursa

Location: Between the superficial and deep layers of the MCL
Distinguishing feature: Vertically orientated fluid within the ligament complex

Parameniscal (medial meniscal) cyst

Location: Adjacent to the medial joint line, communicating with a meniscal tear
Distinguishing feature: Traced to a horizontal meniscal tear (see the meniscus tears topic)

Ganglion / synovial cyst

Location: Variable, may be intratendinous or periarticular
Distinguishing feature: Well defined, often septated, no communication with the bursa

Medial Cystic and Bursal Lesions in the Differential
Lesion	Location	Distinguishing feature
Pes anserine bursa	Deep to conjoined tendons, superficial to distal MCL, anteromedial tibia	Fluid below the joint line at the tendon insertion
Semimembranosus-tibial collateral ligament bursa	Between semimembranosus tendon and superficial MCL, posteromedially at or above the joint line	Sits more posterior and higher than the anserine bursa
MCL (tibial collateral ligament) bursa	Between the superficial and deep layers of the MCL	Vertically orientated fluid within the ligament complex
Parameniscal (medial meniscal) cyst	Adjacent to the medial joint line, communicating with a meniscal tear	Traced to a horizontal meniscal tear (see the meniscus tears topic)
Ganglion / synovial cyst	Variable, may be intratendinous or periarticular	Well defined, often septated, no communication with the bursa

Localise before you label. The rule is anatomical: the anserine bursa lies below the joint line at the conjoined tendon insertion, whereas the semimembranosus-TCL bursa, the MCL bursa and parameniscal cysts sit at or just above it. Axial MRI is the sequence that reliably separates them, with coronal sequences helping to localise the collection.

When the fluid is not anserine. A fluid track to a meniscal tear reclassifies the lesion as a parameniscal cyst, managed as meniscal pathology. A collection at the joint line should prompt review of the MCL and menisci rather than an anserine label.

Four-panel knee MRI of a parameniscal cyst, a bright well-defined collection at the joint line — MRI of a parameniscal cyst in four panels (A-D): a bright, well-defined collection sits at the joint line (A) and is seen again in cross-section (B). Its level, at rather than below the joint line, separates it from anserine fluid.Credit: Hovsepian et al., Clinical Case Reports (CC BY 4.0)

Two-panel ultrasound of the semimembranosus-MCL bursa with blue line markers — Ultrasound of the semimembranosus-MCL bursa in two panels (A, B), with blue line markers, from a guided-injection case. This bursa sits more posterior and higher than the anserine bursa.Credit: Peterson et al., BMC Musculoskeletal Disorders (CC BY 4.0)

Two-panel MRI of the semimembranosus-medial collateral ligament bursa, an asterisk marking the bursa in each — MRI of the semimembranosus-MCL bursa in two panels (A, B), the asterisk marking the bursa in each.Credit: Peterson et al., BMC Musculoskeletal Disorders (CC BY 4.0)

Differential Diagnosis

Medial knee pain has multiple potential causes, and accurate diagnosis depends on the precise location of tenderness and the associated clinical features.

Pes anserine bursitis

Location of Tenderness: 5-6cm below medial joint line
Key Features: Night pain, worse on stairs, no effusion

Medial meniscus tear

Location of Tenderness: Medial joint line
Key Features: Mechanical symptoms, effusion, McMurray positive

MCL injury

Location of Tenderness: At medial joint line, along MCL
Key Features: History of valgus injury, instability on testing

Medial compartment OA

Location of Tenderness: Medial joint line
Key Features: Crepitus, bony enlargement, X-ray changes

Medial plica syndrome

Location of Tenderness: Medial patellofemoral joint
Key Features: Snapping, anterior knee pain, tender band

Saphenous neuritis

Location of Tenderness: Along saphenous nerve distribution
Key Features: Burning pain, paraesthesia, Tinel positive

Differential Diagnosis of Medial Knee Pain
Condition	Location of Tenderness	Key Features
Pes anserine bursitis	5-6cm below medial joint line	Night pain, worse on stairs, no effusion
Medial meniscus tear	Medial joint line	Mechanical symptoms, effusion, McMurray positive
MCL injury	At medial joint line, along MCL	History of valgus injury, instability on testing
Medial compartment OA	Medial joint line	Crepitus, bony enlargement, X-ray changes
Medial plica syndrome	Medial patellofemoral joint	Snapping, anterior knee pain, tender band
Saphenous neuritis	Along saphenous nerve distribution	Burning pain, paraesthesia, Tinel positive

Location is Key

The classic distinguishing feature is the location of maximum tenderness - 5-6cm below the medial joint line - whereas MCL injuries, meniscal pathology and medial compartment osteoarthritis are tender at the joint line. Know it, and know that it fails more often than the textbook admits: in the only MRI series of symptomatic knees on this page, the commonest presentation of MRI-proven anserine bursitis was pain along the medial joint line, mimicking a meniscal tear (Rennie 2005). Distal tenderness therefore rules the diagnosis in; joint-line pain does not rule it out, which is exactly why these patients reach arthroscopy.

Soft-tissue mimics. Semimembranosus insertional tendinopathy is posteromedial tendon disease, whereas the pes anserine bursa lies more anterior and distal. A distal semitendinosus rupture is a traumatic medial-knee mimic that should not be labelled bursitis. A grade-one MCL sprain shows ligament thickening and T2 hyperintensity without fibre discontinuity, which places the abnormality at the joint-line ligament rather than within the distal anserine bursa.

Bony mimic. A stress fracture at the medial tibial plateau shows STIR hyperintensity with a low-signal fracture line. It provides a bony explanation for focal pain below the joint line when radiographs are initially unrevealing.

Ultrasound labelled proximal to distal at the ischial tuberosity, showing an absent semitendinosus tendon beside the conjoint tendon and semimembranosus, with a circled fluid collection — Ultrasound of a semitendinosus rupture, labelled proximal to distal: the semitendinosus tendon is absent (arrow) beside the conjoint tendon and semimembranosus at the ischial tuberosity, with a circled fluid collection. The labels place this tear at the hamstring origin, not at the knee.Credit: Janjua et al., Cureus (CC BY 4.0)

MRI of a grade-one medial collateral ligament sprain, an arrow at the level of the joint line — MRI of a grade-one MCL sprain, the arrow at the level of the joint line.Credit: Ghosh et al., Cureus (CC BY 4.0)

Two-panel MRI of a proximal tibial stress fracture, arrows marking the abnormality beneath the tibial plateau — MRI of a proximal tibial stress fracture in two panels (A, B), the arrows marking the abnormality beneath the tibial plateau, seen as a dark line in B.Credit: Eldesouky et al., Cureus (CC BY 4.0)

Four-panel ultrasound of hypoechoic soft-tissue lesions marked with asterisks and outlined by arrows, panels labelled over the fibula and the tibia — Extra-articular soft-tissue lesions on ultrasound (A-D): hypoechoic areas (asterisks) outlined by arrows, with colour Doppler signal on some panels; A and B are labelled over the fibula and C over the tibia.Credit: Ghouri et al., Clinical Rheumatology (CC BY 4.0)

Management

Treatment is primarily conservative, with corticosteroid injection reserved for cases not responding to initial measures. Addressing the underlying risk factors (obesity, OA, biomechanics) is essential for lasting relief.

Conservative management. Relative rest and symptom control come first, physiotherapy follows, and the maintenance phase returns the patient to activity.

Relative rest from aggravating activities
Ice application 15-20 minutes, 3-4 times daily
NSAIDs (topical or oral) for 2 weeks
Activity modification - avoid stairs, squatting
Night splint or pillow between knees for sleeping

Physiotherapy referral for the programme below
Core stability exercises
Address biomechanical factors

Graduated return to activity
Continue stretching and strengthening
Weight loss, footwear or orthotics, and treatment of underlying OA, as below

Physiotherapy works on flexibility, strength, proprioception and movement pattern.

Stretching

Exercises: Hamstring stretch, ITB stretch, quadriceps stretch
Rationale: Reduce tension on pes anserine complex

Strengthening

Exercises: Hip abductors, VMO, gluteus medius
Rationale: Improve frontal plane control, reduce valgus

Proprioception

Exercises: Single leg stance, wobble board
Rationale: Improve neuromuscular control

Biomechanics

Exercises: Gait retraining, squat technique
Rationale: Address underlying movement dysfunction

Physiotherapy Programme for Pes Anserine Bursitis
Component	Exercises	Rationale
Stretching	Hamstring stretch, ITB stretch, quadriceps stretch	Reduce tension on pes anserine complex
Strengthening	Hip abductors, VMO, gluteus medius	Improve frontal plane control, reduce valgus
Proprioception	Single leg stance, wobble board	Improve neuromuscular control
Biomechanics	Gait retraining, squat technique	Address underlying movement dysfunction

Corticosteroid injection is indicated when conservative measures fail after 4-6 weeks. Local corticosteroid injection is the intervention with the strongest historical trial evidence (Alvarez-Nemegyei 2004), but reported response is variable and best in patients with an ultrasound-confirmed bursa (Yoon 2005).

Position and target. The patient lies supine with the knee slightly flexed (20-30 degrees) on a pillow. The target point overlying the bursa is 2 cm distal and 2 cm medial to the tibial tuberosity.

The steps:

Mark the injection site
Clean the skin with antiseptic
Insert a 25G needle perpendicular to the skin
Advance until periosteum is contacted, then withdraw 2-3 mm
Aspirate to exclude vascular puncture
Inject 1 ml of corticosteroid (e.g. triamcinolone 40 mg) with 2 ml of local anaesthetic

Aftercare. Rest for 24-48 hours with ice, avoid strenuous activity for 2 weeks, and review at 4-6 weeks.

Injection Precautions

Saphenous nerve: direct the needle away from the posterior aspect of the knee; numbness over the anteromedial tibia after injection suggests nerve irritation
Infection: maintain strict aseptic technique
Skin atrophy: inject deep and avoid subcutaneous deposition
Tendon rupture: avoid injecting into the tendon substance
Diabetes: warn about potential blood glucose elevation
Maximum 3 injections: repeated injections risk soft tissue atrophy

Weight. The most important modifiable risk factor: every 1 kg of weight lost reduces knee load by 4 kg. Refer to a dietitian and a weight management programme.

Osteoarthritis. Treat medial compartment OA if present, consider viscosupplementation for concurrent OA, and use unloader bracing if there is significant valgus.

Biomechanics. Orthotics for pes planus, footwear advice (supportive shoes), gait retraining for valgus thrust, and hip strengthening for frontal-plane control.

Surgery is rarely required. Consider it only after failure of comprehensive conservative management including multiple injection attempts; outcomes are variable and it is a last resort. The options:

Arthroscopic bursectomy
Open bursectomy with release of MCL
Excision of concurrent pathology (medial plica, loose bodies)

Prognosis and Outcomes

Pes anserine bursitis generally has a good prognosis with appropriate management. Recurrence is common, however, particularly if the underlying risk factors are not addressed.

After conservative treatment. Most patients improve, and symptoms often improve within 4-6 weeks. Recovery is variable, reported from 10 days to 36 months, and full resolution may take several months.

After injection. The duration of relief is variable, from weeks to months, and a repeat injection may be required. Combine injection with physiotherapy for durable benefit; how injection compares with physiotherapy is taken up under Controversies.

Acute onset, clear precipitant

Unfavorable: Chronic symptoms greater than 6 months

Normal BMI

Unfavorable: Obesity (BMI greater than 30)

No underlying OA

Unfavorable: Severe medial compartment OA

Good compliance with physiotherapy

Unfavorable: Poor engagement with rehabilitation

Modifiable risk factors addressed

Unfavorable: Ongoing contributing factors

Prognostic Factors in Pes Anserine Bursitis
Favorable	Unfavorable
Acute onset, clear precipitant	Chronic symptoms greater than 6 months
Normal BMI	Obesity (BMI greater than 30)
No underlying OA	Severe medial compartment OA
Good compliance with physiotherapy	Poor engagement with rehabilitation
Modifiable risk factors addressed	Ongoing contributing factors

Recurrence Prevention

The key to preventing recurrence is addressing modifiable risk factors: weight loss, correction of biomechanical abnormalities, and maintenance of flexibility and strength. Patients should be counselled that injection provides symptomatic relief but does not address the underlying cause.

Guidelines, Registries & Global Practice

Pes anserine bursitis (or "anserine syndrome") is a clinical diagnosis managed predominantly in primary care, sports medicine and rheumatology worldwide; there is no dedicated implant or device registry. Orthopaedic referral is reserved for diagnostic uncertainty or refractory disease. The most useful evidence comes from epidemiology and small treatment trials, and from major knee osteoarthritis (OA) guidelines, because the bursitis frequently coexists with — and is overshadowed by — medial compartment OA.

Global epidemiology:

MRI prevalence in symptomatic knees

Finding: 2.5% (509 MRI studies, 488 patients, UK)
Source: Rennie 2005

Prevalence in type 2 diabetes

Finding: 36% on clinical exam (94 patients, Israel)
Source: Cohen 1997

Sex distribution

Finding: Strong female predominance (91% of diabetic cases)
Source: Cohen 1997

US-confirmed bursitis among clinically diagnosed cases

Finding: Only 8.7% (26 patients, Korea)
Source: Yoon 2005

Measure	Finding	Source
MRI prevalence in symptomatic knees	2.5% (509 MRI studies, 488 patients, UK)	Rennie 2005
Prevalence in type 2 diabetes	36% on clinical exam (94 patients, Israel)	Cohen 1997
Sex distribution	Strong female predominance (91% of diabetic cases)	Cohen 1997
US-confirmed bursitis among clinically diagnosed cases	Only 8.7% (26 patients, Korea)	Yoon 2005

Side-by-side guideline framing (no society publishes a dedicated pes anserine guideline; relevant guidance comes from knee OA and soft-tissue injection standards):

AAOS (US)

Relevant position: OA CPG supports exercise, weight loss and NSAIDs; intra-articular corticosteroid for OA is limited/inconclusive — extra-articular pes anserine injection is off that scope and used pragmatically

NICE / BOA (UK)

Relevant position: OA guidance prioritises exercise and weight management as core treatment; injections are adjuncts, not first-line; supports conservative-first pathways

EFORT / European consensus

Relevant position: Emphasises addressing biomechanics and OA; image-guided injection where a true bursa is demonstrated

Soft-tissue rheumatology evidence (Alvarez-Nemegyei)

Relevant position: Of NSAIDs, physiotherapy and glucocorticoid injection, only injection had trial-proven efficacy at review

Body	Relevant position
AAOS (US)	OA CPG supports exercise, weight loss and NSAIDs; intra-articular corticosteroid for OA is limited/inconclusive — extra-articular pes anserine injection is off that scope and used pragmatically
NICE / BOA (UK)	OA guidance prioritises exercise and weight management as core treatment; injections are adjuncts, not first-line; supports conservative-first pathways
EFORT / European consensus	Emphasises addressing biomechanics and OA; image-guided injection where a true bursa is demonstrated
Soft-tissue rheumatology evidence (Alvarez-Nemegyei)	Of NSAIDs, physiotherapy and glucocorticoid injection, only injection had trial-proven efficacy at review

Practice variation by resource setting:

High-resource settings: Ready access to diagnostic ultrasound and image-guided injection; ultrasound increasingly used to confirm a true fluid bursa before injecting and to avoid the saphenous nerve.
Limited-resource settings: Diagnosis and landmark-guided injection performed on clinical grounds alone; emphasis on low-cost, high-value measures — activity modification, hamstring and hip-abductor rehabilitation, weight loss and generic NSAIDs.
Universal principle: Outcomes depend more on addressing modifiable drivers (obesity, OA, valgus malalignment, diabetes, training error) than on any single injection, regardless of healthcare system.

Related pages: MCL Injuries and Meniscus Tears for the two diagnoses this is mistaken for and, on Rennie's evidence, mistaken as - joint-line pain does not exclude an anserine bursa; Knee Osteoarthritis for the disease that coexists with this so often that every treatment study on this page was performed in an osteoarthritic cohort, which is the single biggest limit on their transferability; Semitendinosus Anatomy, Gracilis Anatomy and Sartorius Anatomy for the three tendons whose conjoined insertion gives the structure its name and its dynamic valgus-restraining function; Hamstring Injuries for the proximal pathology in the same muscle group that alters loading here; Prepatellar Bursitis and Septic Bursitis for the bursal pathology that genuinely does distend and for the infection that must be excluded before any injection; and Tibial Stress Fractures for the proximal medial tibial stress injury that produces tenderness in the same place and must not be injected.

Controversies and Areas of Uncertainty

The condition is more contested than its textbook simplicity suggests.

Is it actually a bursitis? Imaging frequently fails to demonstrate a fluid-filled bursa. In one ultrasound cohort only 8.7% of clinically diagnosed cases had US-confirmed bursitis (Yoon 2005), and reviews argue for the broader term "anserine syndrome" because the symptomatic structure (bursa, tendon enthesis, or both) is undefined (Helfenstein 2010; Alvarez-Nemegyei 2004).

Pain generator or bystander? Because it coexists with medial compartment OA so often, debate persists over whether the pes anserine region is the true source of pain or a tender accompaniment of OA. This matters: treating the bursitis may give incomplete relief if OA is the driver.

Injection or physiotherapy first? A randomised comparison found no significant difference between corticosteroid injection and physiotherapy at 8 weeks (Sarifakioglu 2016), while older evidence-based appraisal credited only injection with trial-proven efficacy (Alvarez-Nemegyei 2004). The pragmatic position is shared decision-making, with injection offering speed and physiotherapy addressing cause.

Does ultrasound guidance matter? Guidance reliably confirms whether a true bursa is present and helps avoid the saphenous nerve. A clear, consistently quantified accuracy or outcome advantage over landmark injection for this specific target is not well established in high-quality trials, and claims of precise accuracy percentages should be treated with caution.

Biologics and the diabetes link. Platelet-rich plasma and other biologics lack robust topic-specific evidence and remain experimental here. The mechanism behind the strong diabetes association, independent of BMI and glycaemic control, is unexplained.

How to handle the controversy in a viva

Show the examiner you know the term "anserine syndrome" and that the lesion is often a soft-tissue enthesopathy rather than a true bursitis. State that you would confirm the diagnosis clinically (point tenderness below the joint line), exclude OA and meniscal pathology, treat conservatively first, and reserve image-guided injection for confirmed or refractory cases.

MCQ Practice Points

Clinical Pearl

Q: What is the order of tendons in the pes anserinus from superficial to deep?

A: Sartorius, Gracilis, Semitendinosus (SGS). Remember "Say Grace before Semitendinosus" - the sartorius is most superficial (from ASIS), gracilis is middle (from pubis), and semitendinosus is deepest (from ischial tuberosity). All three are knee flexors and tibial internal rotators.

Clinical Pearl

Q: What is the key anatomical landmark distinguishing pes anserine bursitis from medial meniscus or MCL pathology?

A: Tenderness 5-6cm BELOW the medial joint line. MCL injuries and meniscal tears cause tenderness AT the joint line. The pes anserine bursa lies on the anteromedial proximal tibia, between the conjoined tendon insertion and the tibial attachment of the MCL.

Clinical Pearl

Q: What nerve is at risk during corticosteroid injection for pes anserine bursitis?

A: The infrapatellar branch of the saphenous nerve. This nerve runs in close proximity to the pes anserinus, anterior to the sartorius tendon. To minimize risk, direct the needle away from the posterior aspect of the knee. Ultrasound guidance improves placement accuracy over the blind landmark technique and confirms whether a true fluid-filled bursa is present.

Clinical Pearl

Q: A 55-year-old obese woman with knee OA presents with medial knee pain worse at night lying on the affected side. What is the most likely diagnosis?

A: Pes anserine bursitis. The classic triad is obesity, knee OA, and female gender (marked female predominance). Night pain when lying on the affected side is characteristic of bursal inflammation from direct pressure. Diabetes is a strong, independent risk factor (around 36% of type 2 diabetics affected in Cohen's series). Pain is also worse on stairs and rising from chairs.

Clinical Pearl

Q: What is the correct injection target for pes anserine bursa injection using landmarks?

A: 2cm distal AND 2cm medial to the tibial tuberosity. Insert a 25G needle perpendicular to skin, advance to periosteum then withdraw 2-3mm. Inject triamcinolone 40mg with 2ml local anaesthetic. Maximum 3 injections due to soft tissue atrophy risk.

Clinical Decision Scenarios

Practise clinical reasoning and management decisions out loud

Viva scenarioStandard

Clinical prompt

“In pes anserine bursitis, tenderness is located 5-6cm BELOW the medial joint line on the anteromedial proximal tibia - this is the key distinguishing feature. Other causes of medial knee pain have different sites of maximum tenderness.”

Viva scenarioStandard

Clinical prompt

“The examiner is testing anatomical knowledge relevant to injection technique and understanding of the pathology.”

Viva scenarioChallenging

Clinical prompt

“This tests understanding of the multifactorial nature of the condition and comprehensive management approach.”

Viva scenarioStandard

Clinical prompt

“The examiner wants you to demonstrate clinical reasoning and examination skills.”

Viva scenarioChallenging

Clinical prompt

“The examiner is assessing injection technique safety awareness.”

Exam day cheat sheet

PES ANSERINE BURSITIS

ANATOMY

SGS = Sartorius, Gracilis, Semitendinosus (superficial to deep)
Location: anteromedial proximal tibia, 5-6cm below medial joint line
Bursa lies between pes anserine tendons and MCL insertion
Saphenous nerve at risk - runs anterior to sartorius

CLINICAL FEATURES

Tenderness 5-6cm below medial joint line - KEY distinguishing feature
Night pain worse lying on affected side
Pain on stairs, rising from chair, pivoting
No joint effusion (unlike meniscal/ligament injury)
Positive resisted knee flexion and internal rotation

RISK FACTORS

Obesity and Osteoarthritis
Women (4:1) and Wrong biomechanics (valgus, pes planus)
Loading errors (training mistakes, sudden increase in activity)
Also diabetes (strong independent association, ~36% of type 2 diabetics)

DIFFERENTIAL

MCL injury - tenderness AT joint line, history of valgus injury
Medial meniscus tear - joint line tender, mechanical symptoms, effusion
Medial compartment OA - joint line, crepitus, X-ray changes
Saphenous neuritis - burning pain, Tinel positive

IMAGING

X-ray: usually normal, exclude OA and bony pathology
Ultrasound: investigation of choice, bursa greater than 2mm thickness
MRI: reserved for diagnostic uncertainty, shows high T2 signal
Clinical diagnosis primarily - imaging for confirmation or differential

INJECTION TECHNIQUE

Target: 2cm distal AND 2cm medial to tibial tuberosity
Triamcinolone 40mg + 2ml local anaesthetic
Direct needle AWAY from posterior knee (saphenous nerve)
Maximum 3 injections - risk of soft tissue atrophy
Ultrasound guidance improves placement and confirms a true bursa

MANAGEMENT PEARLS

Address underlying factors: obesity, OA, biomechanics
Physiotherapy: hamstring stretch, hip abductor strengthening
Most respond to conservative measures (recovery variable)
Injection for refractory cases - fastest relief, comparable medium-term outcome
Surgery rarely indicated - last resort only

Evidence Base

Evidence

Sarifakioglu B, Afsar SI, Yalbuzdag SA, et al. Comparison of physical therapy and corticosteroid injection in pes anserine tendino-bursitis. J Phys Ther Sci. 2016

Level II (RCT)

Key Findings:

Randomised: physiotherapy vs corticosteroid injection (n=60 with PATB)
Both effective; no significant difference at 8 weeks
Bursitis worsens pain and function over OA alone
Injection a fast, inexpensive option

Finding: 60 patients with knee OA and pes anserine tendino-bursitis were randomised to physical therapy or local corticosteroid injection. Both groups improved significantly in VAS, WOMAC and timed up-and-go at 8 weeks, with no significant difference between treatments. A separate cohort of 57 OA patients without bursitis confirmed bursitis adds pain and disability.

Clinical implication: Physiotherapy and corticosteroid injection are comparably effective. Reserve injection for patients wanting rapid relief or failing conservative care; combine with rehab for durable benefit.

Limitation: SIXTY PATIENTS, ALL WITH KNEE OSTEOARTHRITIS, AND NO UNTREATED ARM - both groups improved and neither beat the other, but with about 30 per arm and an eight-week endpoint this excludes only a large difference, and without a control group it cannot separate either treatment from natural history in a condition that often settles on its own. Randomisation was applied after selecting patients who already had osteoarthritis, so nothing here transfers to the younger runner or to a patient without osteoarthritis. Diagnosis was clinical, with no imaging confirmation that a bursa was involved at all. No registered protocol or stated primary endpoint, and the conclusion that injection is 'effective, inexpensive and fast' reflects the authors' framing rather than any measured comparison of cost or time.

Verify on PubMed (PMID 27512249)

Evidence

Rennie WJ, Saifuddin A. Pes anserine bursitis: incidence in symptomatic knees and clinical presentation. Skeletal Radiol. 2005

Level IV (imaging cohort)

Key Findings:

509 MRI studies, 488 patients with knee pain
Prevalence on MRI 2.5%
Often mimics medial meniscal tear clinically
Axial MRI distinguishes bursa from other fluid

Finding: Retrospective review of 509 knee MRI studies in 488 patients with knee pain found pes anserine bursitis in 2.5%. The commonest presentation was medial joint line pain mimicking a medial meniscal tear; axial imaging was needed to distinguish the bursa from other medial fluid collections.

Clinical implication: An accurate MRI diagnosis can prevent unnecessary arthroscopy. Correlate medial joint line pain with the true site of tenderness below the joint line.

Limitation: THIS IS AN MRI-REPORT PREVALENCE, NOT A CLINICAL ONE - 509 scans requested for suspected INTERNAL DERANGEMENT at a tertiary orthopaedic centre, so the denominator is patients whose knee pain was thought mechanical enough to warrant MRI. The 2.5% cannot be read as the frequency of anserine bursitis among people with medial knee pain, and still less among patients with knee osteoarthritis. Cases were identified from radiology REPORTS, so the figure measures what radiologists happened to mention rather than what was present. Retrospective across six years of evolving protocols. Its most useful finding is the one that unsettles the textbook: the commonest presentation was pain along the MEDIAL JOINT LINE mimicking a meniscal tear, not the classic tenderness several centimetres distal.

Verify on PubMed (PMID 15940489)

Evidence

Cohen SE, Mahul O, Meir R, Rubinow A. Anserine bursitis and non-insulin dependent diabetes mellitus. J Rheumatol. 1997

Level III (case-control)

Key Findings:

36% of type 2 diabetics had anserine bursitis
91% of affected patients were women
Independent of age, BMI and glycaemic control
Strong female predominance confirmed

Finding: Among 94 consecutive patients with type 2 diabetes, 34 (36%) had clinically diagnosed anserine bursitis versus far fewer non-diabetic controls; 91% of affected patients were women. The association was independent of age, BMI, diabetes duration and glycaemic control (HbA1c).

Clinical implication: Have a low threshold to examine the pes anserine region in diabetic patients with medial knee pain; the link is independent of weight and diabetic control.

Limitation: DIAGNOSIS WAS PURELY CLINICAL - 'knee pain and tenderness at the bursal site' - with no imaging, in a study predating the ultrasound and MRI work showing most such patients have no demonstrable bursa. The 36% is therefore the prevalence of a SIGN, not of a pathological entity, and medial tibial tenderness is common in diabetes for other reasons including neuropathy. Ninety-four diabetic patients against 57 controls at a single tertiary hospital, with a striking sex imbalance in the finding (31 of 34 affected were women) that the study is too small to disentangle from the cohort's own sex distribution. Nothing reached significance for age, BMI, duration or glycaemic control, so the association attaches to the diabetes label rather than to any measured feature of the disease, and no mechanism is offered.

Verify on PubMed (PMID 9375878)

Evidence

Yoon HS, Kim SE, Suh YR, et al. Correlation between ultrasonographic findings and response to corticosteroid injection in pes anserinus tendinobursitis. J Korean Med Sci. 2005

Level IV (prospective cohort)

Key Findings:

Only 8.7% had US-confirmed bursitis despite clinical diagnosis
Corticosteroid injection improved VAS and WOMAC
US-positive patients had the best response
Many clinically diagnosed cases lack a true bursa lesion

Finding: In 26 knee OA patients with clinically diagnosed pes anserine syndrome, only 2 (8.7%) showed ultrasound evidence of true bursitis. Of 17 injected with triamcinolone, VAS and WOMAC pain and function improved significantly; the two best responders were precisely those with ultrasound-confirmed bursitis.

Clinical implication: The clinical syndrome is frequently a tendinopathy or enthesopathy rather than a fluid-filled bursa. Ultrasound helps select patients most likely to benefit from injection.

Limitation: TWENTY-SIX PATIENTS, ONLY SEVENTEEN INJECTED, AND THE HEADLINE FINDING CUTS BOTH WAYS - that just 8.7% had ultrasound-confirmed bursitis is the strongest single argument that the clinical diagnosis does not identify a bursa, but it rests on 2 patients of 23 scanned with a 7 MHz transducer in 2005, and ultrasound sensitivity for a thin, non-distended bursa is poor. The claim that the two best responders were the two with ultrasound evidence is a two-patient observation and cannot support selecting patients for injection. No control arm, no blinding, outcomes assessed by the treating team. Every patient had knee osteoarthritis, so an injection near the medial knee may act on the joint rather than the bursa - exactly the confounder this design cannot exclude.

Verify on PubMed (PMID 15716614)

Evidence

Helfenstein M Jr, Kuromoto J. Anserine syndrome. Rev Bras Reumatol. 2010

Narrative review

Key Findings:

Imaging frequently cannot confirm true bursitis
Diabetes is the best-established risk factor
Recovery highly variable (10 days to 36 months)
Pathoanatomy remains uncertain

Finding: Argues for the umbrella term 'anserine syndrome' because imaging often fails to confirm a discrete bursitis. Diabetes is an established predisposing factor; obesity and knee OA are probable additional risks. Response to NSAIDs, physiotherapy and corticosteroid injection is highly variable, with recovery times ranging from 10 days to 36 months.

Clinical implication: Counsel patients that recovery is variable and the lesion is often a soft-tissue enthesopathy rather than a true bursitis; manage expectations accordingly.

Limitation: A NARRATIVE REVIEW WRITTEN TO PROPOSE A NAME RATHER THAN TO SETTLE A QUESTION - the authors argue for 'anserine syndrome' precisely because the evidence cannot say whether the lesion is bursitis, tendinitis or both, and they state plainly that 'little is known regarding the structural defect responsible'. The recovery range it reports - 10 days to 36 months - is assembled from heterogeneous studies using different diagnostic criteria, so it describes the spread of the literature rather than a prognosis you can give a patient, and the long tail may reflect misdiagnosis as much as refractory disease. No search strategy, and published in a regional journal with limited indexing. Cite it for the terminology and the uncertainty, not for numbers.

Verify on PubMed (PMID 21125167)

Evidence

Alvarez-Nemegyei J, Canoso JJ. Evidence-Based Soft Tissue Rheumatology IV: Anserine Bursitis. J Clin Rheumatol. 2004

Evidence-based review

Key Findings:

Only glucocorticoid injection had trial-proven efficacy at the time
NSAID and physiotherapy evidence was weak
Diagnosis is clinical (inferomedial tenderness)
Significant knowledge gaps in pathogenesis

Finding: Critical appraisal of treatment evidence concludes that of the common interventions (NSAIDs, physiotherapy, local glucocorticoid injection) only local glucocorticoid injection has demonstrated efficacy in clinical trials. The structure responsible for symptoms remains undefined.

Clinical implication: Corticosteroid injection has the strongest historical evidence base; use it judiciously alongside rehabilitation while addressing modifiable risk factors.

Limitation: A TWO-PAGE EVIDENCE-BASED REVIEW, AND ITS CENTRAL STATEMENT IS AN ADMISSION - 'despite its name, the structure at fault causing the symptoms remains unknown'. Everything downstream inherits that: the authors identify local glucocorticoid injection as the only treatment shown effective in clinical trials, but those trials are few, small and mostly in knee osteoarthritis cohorts, and none was placebo-controlled against the natural history of a condition that often settles on its own. Overweight and knee osteoarthritis are named as possible risk factors with the explicit caveat that their role has yet to be assessed. Two pages, no systematic search reported, so it is a well-informed expert synthesis rather than an evidence appraisal. Its lasting value is the honesty about what is not known.

Verify on PubMed (PMID 17043509)